☰

Walter J. Jessen, Ph.D. - Publications

Affiliations: 
2004 Texas A & M University, College Station, TX, United States 
Area:
Biochemistry, Molecular Biology
Tree Info Similar researchers PubMed Report error

7/23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Jessen WJ, Borgerding MF, Prasad GL. Global methylation profiles in buccal cells of long-term smokers and moist snuff consumers. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 1-51. PMID 29771158 DOI: 10.1080/1354750X.2018.1466367  0.339
2012 Patel AV, Eaves D, Jessen WJ, Rizvi TA, Ecsedy JA, Qian MG, Aronow BJ, Perentesis JP, Serra E, Cripe TP, Miller SJ, Ratner N. Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5020-30. PMID 22811580 DOI: 10.1158/1078-0432.Ccr-12-1072  0.303
2009 Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, Muir D, Wallace MR, Lopez E, Serra E, Nielsen GP, et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. Embo Molecular Medicine. 1: 236-48. PMID 20049725 DOI: 10.1002/Emmm.200900027  0.325
2007 Liu X, Jessen WJ, Sivaganesan S, Aronow BJ, Medvedovic M. Bayesian hierarchical model for transcriptional module discovery by jointly modeling gene expression and ChIP-chip data. Bmc Bioinformatics. 8: 283. PMID 17683565 DOI: 10.1186/1471-2105-8-283  0.349
2006 Jessen WJ, Hoose SA, Kilgore JA, Kladde MP. Active PHO5 chromatin encompasses variable numbers of nucleosomes at individual promoters. Nature Structural & Molecular Biology. 13: 256-63. PMID 16491089 DOI: 10.1038/Nsmb1062  0.71
2004 Jessen WJ, Dhasarathy A, Hoose SA, Carvin CD, Risinger AL, Kladde MP. Mapping chromatin structure in vivo using DNA methyltransferases. Methods (San Diego, Calif.). 33: 68-80. PMID 15039089 DOI: 10.1016/J.Ymeth.2003.10.025  0.546
2003 Carvin CD, Dhasarathy A, Friesenhahn LB, Jessen WJ, Kladde MP. Targeted cytosine methylation for in vivo detection of protein-DNA interactions. Proceedings of the National Academy of Sciences of the United States of America. 100: 7743-8. PMID 12808133 DOI: 10.1073/Pnas.1332672100  0.545
Low-probability matches (unlikely to be authored by this person)
2007 Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen X, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biology. 8: R131. PMID 17615082 DOI: 10.1186/Gb-2007-8-7-R131  0.289
2008 Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, Vickers AJ, Gerald WL, Abate-Shen C. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Research. 68: 2132-44. PMID 18381418 DOI: 10.1158/0008-5472.Can-07-6055  0.284
2016 Wu J, Keng V, Patmore DM, Kendall JJ, Patel AV, Jousma E, Jessen WJ, Choi K, Tschida BR, Silverstein KA, Fan D, Schwartz EB, Fuchs JR, Zou Y, Kim MO, et al. Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation. Cell Reports. PMID 26904939 DOI: 10.1016/J.Celrep.2016.01.074  0.281
2010 Hummel TR, Jessen WJ, Miller SJ, Kluwe L, Mautner VF, Wallace MR, Lázaro C, Page GP, Worley PF, Aronow BJ, Schorry EK, Ratner N. Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5048-57. PMID 20739432 DOI: 10.1158/1078-0432.Ccr-10-0613  0.281
2011 Comstock CE, Augello MA, Schiewer MJ, Karch J, Burd CJ, Ertel A, Knudsen ES, Jessen WJ, Aronow BJ, Knudsen KE. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function. The Journal of Biological Chemistry. 286: 8117-27. PMID 21212260 DOI: 10.1074/Jbc.M110.170720  0.275
2020 Fletcher JS, Wu J, Jessen WJ, Pundavela J, Dombi E, Kim M, Rizvi TA, Chetal K, Salomonis N, Ratner N. Abstract B32: Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-B32  0.254
2019 Fletcher JS, Wu J, Jessen WJ, Pundavela J, Miller JA, Dombi E, Kim MO, Rizvi TA, Chetal K, Salomonis N, Ratner N. Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice. Jci Insight. 4. PMID 30728335 DOI: 10.1172/Jci.Insight.98601  0.252
2012 Keng VW, Rahrmann EP, Watson AL, Tschida BR, Moertel CL, Jessen WJ, Rizvi TA, Collins MH, Ratner N, Largaespada DA. PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors. Cancer Research. 72: 3405-13. PMID 22700876 DOI: 10.1158/0008-5472.Can-11-4092  0.25
2008 Shen H, Powers N, Saini N, Comstock CE, Sharma A, Weaver K, Revelo MP, Gerald W, Williams E, Jessen WJ, Aronow BJ, Rosson G, Weissman B, Muchardt C, Yaniv M, et al. The SWI/SNF ATPase Brm is a gatekeeper of proliferative control in prostate cancer. Cancer Research. 68: 10154-62. PMID 19074882 DOI: 10.1158/0008-5472.Can-08-1794  0.249
2012 Jessen WJ, Landschulz KT, Turi TG, Reams RY. Mining PubMed for Biomarker-Disease Associations to Guide Discovery Nature Precedings. 7: 1-1. DOI: 10.1038/Npre.2012.6941.1  0.245
2013 Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, et al. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. The Journal of Clinical Investigation. 123: 340-7. PMID 23221341 DOI: 10.1172/Jci60578  0.236
2007 Banach-Petrosky W, Jessen WJ, Ouyang X, Gao H, Rao J, Quinn J, Aronow BJ, Abate-Shen C. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. Cancer Research. 67: 9089-96. PMID 17909013 DOI: 10.1158/0008-5472.Can-07-2887  0.228
2013 Tanaka K, Eskin A, Chareyre F, Jessen WJ, Manent J, Niwa-Kawakita M, Chen R, White CH, Vitte J, Jaffer ZM, Nelson SF, Rubenstein AE, Giovannini M. Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3856-70. PMID 23714726 DOI: 10.1158/1078-0432.Ccr-12-3167  0.227
2012 Jessen WJ, Landschulz KT, Turi TG, Reams RY. Mining PubMed for biomarker-disease associations to guide discovery F1000research. 3. DOI: 10.7490/F1000Research.1089905.1  0.218
2015 Jessen W, Sefton J, Phillips J, Gitter B. Connecting Alzheimer's disease, Parkinson's disease, and type 2 diabetes through disease network models and enrichment analyses F1000research. 6. DOI: 10.7490/F1000Research.1097790.1  0.187
2023 Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, Reuter VE, Scardino PT, Shen MM, Aronow BJ, Vickers AJ, Gerald WL, Abate-Shen C. Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer. Cancer Research. 83: 1161. PMID 37014042 DOI: 10.1158/0008-5472.CAN-23-0515  0.151
Hide low-probability matches.